- NCIt
- C53555
Loading cancer entity…
Loading cancer entity…
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04118062 | Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) | completed | N/A | 128 | Institut CurieOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT03715959 | Nipple Aspirate Fluid in Detecting Breast Cancer | completed | N/A | 2 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT03356860 |
| Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.(B-IMMUNE) |
| completed |
| Phase 1 / Phase 2 |
| 57 |
| Grand Hôpital de CharleroiOTHER |
| 1 |
| Nov 20, 2024 |
| clinicaltrials |
| NCT05163106 | Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole(NEOLETRIB) | completed | Phase 2 | 85 | University Hospital, AkershusOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT03860740 | Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients(EFIK) | completed | — | 12 | Spanish Breast Cancer Research GroupOTHER | 1 | Jan 13, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Sep 19, 2025source: clinicaltrials